Gregory Yanik, M.D. – FDA Inspection, Apr 11, 2017

Record Details

This FDA Inspection record concerns Gregory Yanik, M.D., with an inspection on April 11, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Gregory Yanik, M.D.
Inspection Date: April 11, 2017
Product Type: Biologics
Office: Center for Biologics Evaluation and Research
Person: Andrace Deyampert (FDA Associated Person)

View Company Profile

ID · 09662c36-422c-4731-860c-cd13d0c9d3eb

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1010701
FDA center: Biologics
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gregory Yanik, M.D.

FDA Inspection

Gregory Yanik, M.D.April 11, 2017